What a clown call that was. First you have the German Fonz, talking about the differences between the phase 1/2 and the phase 3 and why results weren’t as good. Kinda like making excuses.
Phase 1/2 were scheduled surgeries, at an average age of 65, who were able to be given physio in an controlled situation dictated by the German Fonz himself. Phase 3 an average age of 75, not a scheduled operation, and no ability to control rehab other than suggestions.
It’s called real world data not cherry picked patients. Crazy concept. And didn’t I just say that earlier. Just a simple concept that has happened with ALL their perfect record of failed indications.
Then they explained how they went after the SPPB for their endpoint because others INCLUDING Novartis, did as well. Monkey see monkey do. Then they realized may not have been the best idea and it was 5 years ago and things change.
Finally you have Kaki spewing off about the companies new found FOCUS. Said it like 10 times in a minute. Now they are laser focused to think of other indications to try.. NOW they are focused on finding partners too. Before they were apparently focused on non-dilutive funding, even though they probably raised $300,000,000 in DILUTIVE funding.
But glad they’ve switched to the partnership strategy. Wow could have sworn the OG clown has been saying partnerships HAS BEEN their strategy for for well over a decade. Maybe they’re going to now focus on that Japanese partner that should happen by 2016. You know, because they’re fast tracked in Japan.
Then you have the CMO fumbling around trying to answer a question, like a little school girl nervous as hell to get up in front of the class. Drawing blanks like she said out loud.
Well at least we know the reason they’ve never given a clown call before. Well done boys…well done!!! This company truly gets more laughable by the day. And they did it. Down to a single loonie. That’s a buck to those south of 48
